Science
DeepBAR: AI-Based Technique That May Speed Drug Discovery – Genetic Engineering & Biotechnology News
DeepBAR is a new technique that combines chemistry and machine learning to speed up calculations of drug molecules’ binding affinity to proteins.
A new technique, DeepBAR, quickly calculates the binding affinities between drug candidates and their targets. The approach, which combines chemistry and machine learning, could lower a hurdle in the drug discovery process. DeepBAR yields precise calculations in a fraction of the time compared to previous state-of-the-art methods. The inventors say DeepBAR could one day quicken the pace of drug discovery and protein engineering.
“Our method is orders of magnitude faster than before, meaning we can…
-
Noosa News13 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General14 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
General24 hours agoThe Billion Dollar Balcony. ASIO’s sovereignty failure
-
General11 hours agoIncreased police powers begin at Adelaide Oval Ashes Test following Bondi attacks